Dr. Wang Hui
WEGO HOLDING COMPANY LIMITED (“WEGO”) was established in March 1988, and it principal business focus on medical devices and pharmaceuticals. In addition, WEGO develops some other business such as real estate and investment. WEGO has 8 industry groups and more than 30 subsidiaries. WEGO Holding's subsidiary ---SHANDONG WEIGAO GROUP MEDICAL POLYMER CO., LIMITED is listed in Hong Kong.
The main products of WEGO are infusion sets, syringes, blood transfusion equipments, heart stents, intracardiac consumables,IV catheters and special needles, blood purification equipments and consumables, orthopedic materials, operating room equipments and accessories, wound care products, minimally invasive instruments and equipments, ICU products and accessories, high-capacity injections and pharmaceuticals, renal products, biological diagnostic reagents, PVC & non-PVC materials and so on. WEGO now has products in more than 30 series, 400 categories and 60,000 specifications products, and has become one of the most reliable suppliers of medical system solutions in the world. At the same time, WEGO actively takes part in healthcare service and provides renal dialysis service.
In addition, under the branding strategy, the WEGO products are sold in more than 30 provinces and municipalities, which covered 81.3% of tertiary hospitals and 77.2% of blood banks in China, and also exported to over 70 countries and areas. WEGO is trying to become an international company, trying to achieve the vision of “To be one of the global elites; Pioneer in Asia; Most respectable medical device and medication enterprise”, and trying to make contributions to China's medical and healthcare industry.
The main products of WEGO are infusion sets, syringes, blood transfusion equipments, heart stents, intracardiac consumables,IV catheters and special needles, blood purification equipments and consumables, orthopedic materials, operating room equipments and accessories, wound care products, minimally invasive instruments and equipments, ICU products and accessories, high-capacity injections and pharmaceuticals, renal products, biological diagnostic reagents, PVC & non-PVC materials and so on. WEGO now has products in more than 30 series, 400 categories and 60,000 specifications products, and has become one of the most reliable suppliers of medical system solutions in the world. At the same time, WEGO actively takes part in healthcare service and provides renal dialysis service.
In addition, under the branding strategy, the WEGO products are sold in more than 30 provinces and municipalities, which covered 81.3% of tertiary hospitals and 77.2% of blood banks in China, and also exported to over 70 countries and areas. WEGO is trying to become an international company, trying to achieve the vision of “To be one of the global elites; Pioneer in Asia; Most respectable medical device and medication enterprise”, and trying to make contributions to China's medical and healthcare industry.
WeiGao Group
BDDr. Karen Hung
OneWorld Diagnostics is a German biotech company which focuses on veterinary diagnostics solutions and R&D tools and products. With our professional services and customized research solution, OneWorld Diagnostics is a trusted contract research organization specializing in diagnostic assay development and tech transfer. We are the trusted partner of the Top 5 international and Chinese pharmaceutical companies.
Our expertise is in developing research solution particularly in microbiology, molecular and immunology assay development and tech transfer in China and European markets.
Our expertise is in developing research solution particularly in microbiology, molecular and immunology assay development and tech transfer in China and European markets.